Literature DB >> 21871959

A comparative study on the effectiveness of cis- and trans-form of cinnamic acid treatments for inhibiting invasive activity of human lung adenocarcinoma cells.

Gow-Chin Yen1, Yen-Ling Chen, Fang-Ming Sun, Yu-Ling Chiang, Shiau-Huei Lu, Chia-Jui Weng.   

Abstract

Lung cancer is the major cause of tumor-related death, and approximately 70% of lung cancer patients die from metastasis. Evidence that phenolic compounds may have a potential inhibitory effect on cancer invasion and metastasis is increasingly being reported in the scientific literature. Cinnamic acid is a member of phenolics which having several isoforms in nature. The trans-cinnamic acid (t-CA) has been investigated extensively for its potential pharmacological effects whereas the study of cis-cinnamic acid (c-CA) is limited because pure c-CA was hard to obtain. We had developed a practicable method previously to transform and obtain pure c-CA, and the pure compound was used to evaluate the anti-invasive effect on human adenocarcinoma A549 cells. The A549 cells were treated with 0-200 μM of c-CA and t-CA in the presence of 200 nM phorbol-12-myristate-13-acetate (PMA) at 37 °C for 24 h, and matrix metalloproteinase (MMP)-2, MMP-9, adhesive, migratory, and invasive activities of the cells were determined. The results showed that the treatment of c-CA and t-CA dose-dependently reduced the PMA-induced MMP-2 and -9 activities but without significant effect on the adhesive activity of cells. The PMA-induced motility was suppressed in a dose-dependent manner by a 24-h treatment with c-CA and t-CA. The invasive ability was significantly (p<0.05) reduced to 68% and 65%, respectively, relative to PMA treatment alone after treatment of PMA-treated A549 cells with either 50 μM c-CA or 100 μM t-CA for 24 h. The results suggest that both of the c-CA and t-CA are inhibitors for invasion of A549 cells and the activity of c-CA seems to be higher than t-CA.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21871959     DOI: 10.1016/j.ejps.2011.08.006

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

1.  Understanding the role played by protic ionic liquids (PILs) and the substituent effect for enhancing the generation of Z-cinnamic acid derivatives†.

Authors:  Rocío B Rodríguez; Ramiro L Zapata; María L Salum; Rosa Erra-Balsells
Journal:  Photochem Photobiol Sci       Date:  2020-10-27       Impact factor: 3.982

2.  Phytochemical profiling and cytotoxic evaluation of Premna serratifolia L. against human liver cancer cell line.

Authors:  Kavindra Nath Tiwari; Sunil Kumar Mishra; Poonam Kakkar; Chandrashekhar Singh; Sumit Kumar Anand
Journal:  3 Biotech       Date:  2021-02-05       Impact factor: 2.406

3.  Myeloperoxidase Inhibitory and Antioxidant Activities of (E)-2-Hydroxy-α-aminocinnamic Acids Obtained through Microwave-Assisted Synthesis.

Authors:  Astrid Rivera-Antonio; Martha Cecilia Rosales-Hernández; Irving Balbuena-Rebolledo; José Martín Santiago-Quintana; Jessica Elena Mendieta-Wejebe; José Correa-Basurto; Juan Benjamín García-Vázquez; Efrén Venancio García-Báez; Itzia I Padilla-Martínez
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

4.  The Profile and Bioaccessibility of Phenolic Compounds in Cereals Influenced by Improved Extrusion Cooking Treatment.

Authors:  Zicong Zeng; Chengmei Liu; Shunjing Luo; Jun Chen; Ersheng Gong
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

5.  Geijigajakyak decoction inhibits the motility and tumorigenesis of colorectal cancer cells.

Authors:  Soong-In Lee; Jeong A Bae; Yoo-Seung Ko; Kyoung-In Lee; Hangun Kim; Kyung Keun Kim
Journal:  BMC Complement Altern Med       Date:  2016-08-15       Impact factor: 3.659

6.  Design and Synthesis of Molecular Hybrids of Sophora Alkaloids and Cinnamic Acids as Potential Antitumor Agents.

Authors:  Hai Shang; Lingyu Li; Liyan Ma; Yu Tian; Hongmei Jia; Tao Zhang; Meng Yu; Zhongmei Zou
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.